Your browser doesn't support javascript.
loading
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region.
Schoeder, Clara T; Gilchuk, Pavlo; Sangha, Amandeep K; Ledwitch, Kaitlyn V; Malherbe, Delphine C; Zhang, Xuan; Binshtein, Elad; Williamson, Lauren E; Martina, Cristina E; Dong, Jinhui; Armstrong, Erica; Sutton, Rachel; Nargi, Rachel; Rodriguez, Jessica; Kuzmina, Natalia; Fiala, Brooke; King, Neil P; Bukreyev, Alexander; Crowe, James E; Meiler, Jens.
  • Schoeder CT; Department of Chemistry, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Gilchuk P; Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Sangha AK; Institute for Drug Discovery, University Leipzig Medical School, Leipzig, Germany.
  • Ledwitch KV; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Tennessee, United States of America.
  • Malherbe DC; Department of Chemistry, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Zhang X; Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Binshtein E; Department of Chemistry, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Williamson LE; Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Martina CE; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Dong J; Galveston National Laboratory, Galveston, Texas, United States of America.
  • Armstrong E; Department of Chemistry, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Sutton R; Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Nargi R; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Tennessee, United States of America.
  • Rodriguez J; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Tennessee, United States of America.
  • Kuzmina N; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Fiala B; Department of Chemistry, Vanderbilt University, Nashville, Tennessee, United States of America.
  • King NP; Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
  • Bukreyev A; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Tennessee, United States of America.
  • Crowe JE; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Tennessee, United States of America.
  • Meiler J; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Tennessee, United States of America.
PLoS Pathog ; 18(5): e1010518, 2022 05.
Article en En | MEDLINE | ID: mdl-35584193

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article